Home - Products - Others - Other Targets - 1-O-trans-cinnamoyl-β-D-glucopyranose

1-O-trans-cinnamoyl-β-D-glucopyranose

CAS No. 40004-96-4

1-O-trans-cinnamoyl-β-D-glucopyranose( ——— )

Catalog No. M39798 CAS No. 40004-96-4

1-O-trans-Cinnamoyl-β-D-glucopyranose is a nature product. 1-O-trans-Cinnamoyl-β-D-glucopyranose can be isolated from fruits.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 317 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-O-trans-cinnamoyl-β-D-glucopyranose
  • Note
    Research use only, not for human use.
  • Brief Description
    1-O-trans-Cinnamoyl-β-D-glucopyranose is a nature product. 1-O-trans-Cinnamoyl-β-D-glucopyranose can be isolated from fruits.
  • Description
    1-O-trans-Cinnamoyl-β-D-glucopyranose is a nature product. 1-O-trans-Cinnamoyl-β-D-glucopyranose can be isolated from fruits.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    40004-96-4
  • Formula Weight
    310.302
  • Molecular Formula
    C15H18O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Latza, et al. 1-O-trans-cinnamoyl-β-D-glucopyranose:alcohol cinnamoyltransferase activity in fruits of cape gooseberry (Physalis peruviana). Zeitschrift fuer Naturforschung, C: Biosciences (1997), 52(11/12), 747-755
molnova catalog
related products
  • Flaviviruses-IN-3

    Flaviviruses-IN-3 (compound 87) is a potent inhibitor of flaviviruses, capable of reducing West Nile virus (WNV) protease activity by 54%.

  • Rozanolixizumab

    Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.

  • TGFβ1-IN-3

    TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF).